Etanercept for juvenile rheumatoid arthritis

References

Citations

1. Bathon JM, et al. (2000). A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. New England Journal of Medicine, 343(22): 1586–1593.

2. Klippel JH (2000). Biologic therapy for rheumatoid arthritis. New England Journal of Medicine, 343(22): 1640–1641.

3. Reiff A, et al. (2001). Etanercept therapy in children with treatment-resistant uveitis. Arthritis and Rheumatism, 44(6): 1411–1415.

4. Culy CR, Keating GM (2003). Spotlight on etanercept in rheumatoid arthritis, psoriatic arthritis, and juvenile rheumatoid arthritis. Biodrugs, 17(2): 139–145.

5. Lovell DJ, et al. (2003). Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis and Rheumatism, 48(1): 218–226.

6. Wargula JC, Lovell DJ (2000). Use of etanercept in children. Bulletin on the Rheumatic Diseases, 49(12): 1–4.

7. Pisetsky DS, St Clair EW (2001). Progress in the treatment of rheumatoid arthritis. JAMA, 286(22): 2787–2790.

Author:	Shannon Erstad, MBA/MPH	Last Updated: June 30, 2006
Medical Review:	Michael J. Sexton, MD - Pediatrics Ross E. Petty, MD, PhD, FRCPC - Pediatric Rheumatology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.